Close



Apr 4, 2024 08:35AM
Mar 28, 2024 02:12PM
Mar 28, 2024 09:02AM
Mar 28, 2024 07:51AM
Mar 27, 2024 08:50AM
Mar 27, 2024 06:31AM
Mar 27, 2024 06:30AM Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Feb 22, 2024 06:31AM
Feb 22, 2024 06:30AM
Feb 22, 2024 06:30AM
Jan 2, 2024 07:11AM
Dec 15, 2023 03:54PM
Dec 15, 2023 03:52PM
Dec 14, 2023 10:38AM 'Unlikely' Moderna can file for accelerated approval says analyst; Shares jump 12%
Dec 14, 2023 06:32AM
Dec 14, 2023 06:30AM
Dec 11, 2023 07:00AM
Dec 11, 2023 06:45AM
Nov 2, 2023 06:30AM
Sep 13, 2023 06:37AM
Sep 13, 2023 06:33AM Moderna (MRNA) Reports Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
Sep 13, 2023 06:30AM
Sep 12, 2023 06:11PM
Sep 12, 2023 05:08AM
Sep 11, 2023 02:26PM
Sep 11, 2023 02:02PM
Sep 11, 2023 01:53PM
Sep 6, 2023 08:32AM Moderna (MRNA) said updated Covid-19 vaccine effective against BA.2.86 (Pirola) variant
Sep 6, 2023 07:00AM
Aug 17, 2023 04:16PM
Aug 17, 2023 04:15PM
Aug 14, 2023 10:00AM
Aug 3, 2023 06:30AM
Jul 26, 2023 06:45AM
Jul 26, 2023 06:45AM Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
Jul 5, 2023 07:01AM
Jul 5, 2023 07:00AM
Jun 22, 2023 06:16PM
Jun 22, 2023 04:06PM
Jun 22, 2023 04:05PM
Jun 15, 2023 04:09PM
Jun 5, 2023 08:01AM Moderna (MRNA) and Merck (MRK) Announce mRNA-4157 in Combination With KEYTRUDA Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Pat
Jun 5, 2023 08:00AM
May 4, 2023 06:30AM
Apr 18, 2023 09:34AM
Apr 17, 2023 07:04AM
Apr 16, 2023 12:04PM
Apr 16, 2023 11:00AM
Apr 11, 2023 07:09AM Moderna (MRNA) Announces Clinical and Program Updates at 4th Vaccines Day
Apr 11, 2023 07:00AM

251,412 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All